Dyslipidemia
Abnormal blood lipid levels — elevated ApoB, LDL or triglycerides, or low HDL. A core cardiovascular-risk axis.
Definition
Dyslipidemia describes any pattern of abnormal blood lipids: elevated ApoB, LDL-cholesterol, triglycerides or non-HDL cholesterol, or reduced HDL. It's a core driver of atherosclerotic cardiovascular disease. Management depends on the specific pattern, underlying metabolic context, and the member's baseline cardiovascular risk; lifestyle, statins and newer agents (PCSK9 inhibitors, bempedoic acid) all have roles.
Read More
ApoBApolipoprotein B
The primary atherogenic protein in blood — a better cardiovascular-risk marker than LDL alone.
BiomarkerLDL CholesterolLow-Density Lipoprotein
The cholesterol carried on low-density lipoproteins — the traditional cardiovascular-risk marker, increasingly supplemented by ApoB.
BiomarkerHDL CholesterolHigh-Density Lipoprotein
The cholesterol carried on high-density lipoproteins — associated with cardiovascular protection but no longer directly targetable.
$149 panel.
A clinician reads it in 24 hours.
Order the Peptide Readiness Panel, draw at a Quest or LabCorp near you, and your clinician sends back a matched protocol with a confidence score.